Related Experiment Video
Updated: Oct 24, 2025
07:16
Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells
Published on: January 21, 2021
3.2K
A Novel Bionic Catalyst-Mediated Drug Delivery System for Enhanced Sonodynamic Therapy
Yiling Yang1, Shaohua Hua1, Weilong Suo2
1Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Frontiers in Bioengineering and Biotechnology
|August 16, 2021
Summary
This study developed an improved cancer therapy using ultrasound-triggered sonodynamic therapy (SDT) with a curcumin-loaded manganese dioxide core. The novel approach reduces tumor hypoxia, enhancing treatment efficacy and tumor inhibition in mouse models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Ultrasound-triggered sonodynamic therapy (SDT) is a promising non-invasive cancer treatment.
- Tumor hypoxia significantly limits the efficacy of oxygen-dependent SDT.
- Developing strategies to overcome tumor hypoxia is crucial for advancing SDT.
Purpose of the Study:
- To develop an innovative, catalyst-based SDT system to overcome tumor hypoxia and enhance cancer treatment.
- To create a multi-functional nanoplatform combining sonosensitizing, oxygen-generating, and tumor-targeting capabilities.
- To evaluate the therapeutic efficacy and anti-tumor effects of the developed system in preclinical models.
Main Methods:
- Fabrication of a hollowed-out manganese dioxide (MnO2) core loaded with sonosensitizing curcumin (Cur).
- Coating the MnO2 core with a tumor cell membrane for enhanced tumor recognition and biomimicry.
- Utilizing the MnO2 core to catalyze oxygen generation from endogenous hydrogen peroxide, alleviating tumor hypoxia.
- Administering the Cur-loaded MnO2 system for ultrasound-triggered SDT and evaluating its anti-cancer effects in vivo.
Main Results:
- The developed biomimetic nanoplatform demonstrated efficient tumor cell recognition and drug delivery.
- The MnO2 core effectively catalyzed oxygen generation, significantly reducing the hypoxic state within tumors.
- Ultrasound-triggered SDT with the novel system exhibited enhanced tumor inhibition and synergistic therapeutic effects in mouse models.
- Curcumin also contributed to the cytotoxic effect, further enhancing tumor suppression.
Conclusions:
- The developed catalyst-based, biomimetic SDT system effectively overcomes tumor hypoxia, leading to enhanced anti-tumor efficacy.
- This innovative approach offers a promising strategy for synergistic sonodynamic therapy and overcoming hypoxia-related challenges in cancer treatment.
- The platform holds potential for treating other conditions characterized by hypoxic states.
Related Concept Videos
01:16Drug Delivery: Overview
488
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
488
01:27Bioavailability Enhancement: Drug Permeability Enhancement
29
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
29